FDA Investigator Yvette E Guillermo

Yvette E Guillermo has inspections in 2 countries as of 27 Oct 2023. Yvette E Guillermo has collaborated with a combinined 3397 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
214
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
A Williams, Ademola O Daramola, Aimee K Contreras, Alexandra B Pitkin, Allen F Hall, Anderson, Andrace Lde Yampert, Andrea A Branche, Angela Shepas, Angele C Smith, Angelica G Aziz, Anthony G Emerson, Armando Chavez, MS, Arsen Karapetyan, Bichsa T Nguyen, Bichsa T Tran, Bowman, Brandon L Blakely, Brian Ravitch, Bryan A Galvez, Burnsb, Carla J Lundi, Carr Sharpe, Carrie A Hughes, Caryn M Mcnab, CDR Cecily Jones, CDR Sean T Creighton, Charles L Larson, Chong Ming Cheng, Chorng M Cheng, Christian D Lynch (CDL), Christine I Shaw, Christopher M Jenner, Claudia Mperez Kasmarski, Courtney N Long, Cynthia L Gorveatt, Daniel J Lahar, Dannie E Rowland, Darren S Brown, David G Whitman, David P Vanhouten, Davis, Deborah A Greco, Dejon N Harris, Diane Cvan Leeuwen, Dianiris C Ayala, Donna Ltartaglino Besone, Dr. Guang Gao, PhD, Durell L Giles, Ebony D Sanon, Elkins, Eric W Anderson, Esther B Gamallo Herrera, F Alex Slizza, Finn A Slizza, Finn Sizza (Alex), Fred R Strominger, Garciam, Gene D Arcy, Geoffrey M Leist, Gilbert Valdez, RS, Herminio C Francisco, Iris C Macinnes, James A Beaulieu, James A Lane, James D Hildreth, James E Bentson, James P Stallings, James P Stumpff, James R Fleckenstein, James R Montero, Janet Pulver, Jasmine N Thompson, Jennifer Alongie Vollom, Jennifer M Gogley, Jenny L Chisem, Jenny L Mccardell, Jeremy H Nguyen, Jinnie Kokiatkulkij, Jocelyn E Massey, Jocelyn E Sparks, Joey V Quitania, John A Gonzalez, John L Stevens, John R Myung, Joseph M Allen, Joshua E Yao, Juanita Banuelos, Juanj N Wu, Juanj Wu, Judy C Nepsa, Kari M Johansen, Katherine E Jacobitz, Kelley, Kelvin Cheung, Kevin N Tran, Kevin T Gerrity, Kham Phommachanh, Kimberly Lewandowski Walker, Kimberly M Lichter, Kirtida Patel, Langer, Lanita F Kelley, Lauren M Lilly, PhD, Leighton K Ngai, Leonard H Lavi, Lilly O Barton, Liming Zhang, Linda Linhn Adams, Linda Thai, Louis B Cencetti, M Jasnethoson Thompson, Maida Henesian (NMI), Maria Isabetejerodel Rio, Mariza M Jafary, Mark C Saale, Marlo Ianm Alintanahin, Mary Ewilkerson Brinsko, Matthew M Vernon, Mei Chen Mu, Michael S Araneta, Minh D Phan, Monica J Wilkins, Monica R Maxwell, Natalie J Ayoub, Nelly N Tran, Nicole D Ruiz, Omotunde I Osunsanmi, Omotunde O Osunsanmi, Othello G Capangpangan, Paul A Bonneau, Paul M Kawamoto, Paula A Trost, Prabhu P Raju, Richmond K Yip, Robert S Sweeton, Robert T Lorenz, Rochelle A Rolnik, Sandra L Shire, DMD, MPA, Santiago Gallardo Johnson, Sara J Dent, Sara Jdent Acosta, Sara M Onyango, Sara M Richardson, Sarah A Hassas, Scott K Zika, Selene T Torres, Shaquenta Y Perkins, Sharon I Gundersen, Shelley H Beausoleil, Sheri L Stephenson, Sherri N Rohlf, MD, Sonya L Karsik, Sparky L Bartee, Stanley B Eugene, BS, BME, State Agency, Stephen R Souza, Steven E Porter, Jr, Stewarte, Sumit Sen, Susan K Bain, Tanya E Malais, Tawny L Colling, Terrance L Thomas, Thanh M Andrews, Thao T Kwan, Theresa Kirkham (NMI), Thomas R Beilke, Timothy P Lafave, Tracey T Duong, Trudy R Papson, Trushani T Desai, Tuan A Nguyen, Uros V Djekic, PhD, Urus V Djckik, Uttaniti Limchumroon (Tom), Vasant G Malshet, PhD, Vashti E Bocker, Vickie L Anderson, Vicky L Cruz, Victor H Loo, Vien Q Le, Virgilio F Pacio, CSO, William D Boden, William J Leonard, William S Vitale, Wr Bowman, Yasamin Ameri, Yehualashet A Gessesse, Youngjd, Yvette E Elacio, Yvonne C Wilkes, Zachary A Bogorad, Zachary L Miller, Zhihao Qiu (Peter), PhD

Yvette E Guillermo's Documents

Publish Date Document Type Title
May, 2001 EIR Phamatech - EIR, 2001-05-04
June, 2003 EIR Magne Vu - EIR, 2003-06-11
September, 2005 FDA 483 Cryocor, Inc - Form 483, 2005-09-20
July, 2011 FDA 483 Organogenesis Inc - Form 483, 2011-07-29
October, 2009 FDA 483 Advanced Rehabilitation Technologies - Form 483, 2009-10-16
March, 2009 EIR Alfa Scientific Designs Inc - EIR, 2009-03-31
June, 2010 FDA 483 Ablation Frontiers Inc - Form 483, 2010-06-11
November, 2005 EIR Diazyme Laboratories - EIR, 2005-11-09
January, 2002 FDA 483 Phamatech - Form 483, 2002-01-15
December, 2008 FDA 483 Response NuVasive Inc - Form 483R, 2008-12-10
February, 2004 EIR Defender SD Manufacturing LLC - EIR, 2004-02-24
April, 2003 FDA 483 Response Plus Orthopedics USA - Form 483R, 2003-06-01
July, 2007 FDA 483 NuVasive Inc - Form 483, 2007-07-02
June, 2011 FDA 483 Surgistar Inc - Form 483, 2011-06-30
January, 2002 FDA 483 Bioserv Corporation - Form 483, 2002-01-30
April, 2003 FDA 483 Plus Orthopedics USA - Form 483, 2003-04-23
September, 2003 FDA 483 CareFusion 303, Inc. - Form 483, 2003-09-25
October, 2009 FDA 483 Medical Equipment Device Specialists - Form 483, 2009-10-16
December, 2008 FDA 483 NuVasive Inc - Form 483, 2008-11-18
July, 2011 FDA 483 Response Organogenesis Inc - Form 483R, 2011-08-04
July, 2011 FDA 483 DJO, LLC - Form 483, 2011-07-14
May, 2001 FDA 483 Response Phamatech - Form 483R, 2001-06-04
June, 2009 FDA 483 Zest Anchors Inc - Form 483, 2009-06-18
March, 2008 FDA 483 Synergy Health AST, LLC - Form 483, 2008-03-26
July, 2003 EIR BioMedical Life Systems, Inc. - EIR, 2003-07-17
March, 2010 FDA 483 Abbott Medical Optics Inc (AMO) - Form 483, 2010-03-30
September, 2003 EIR CareFusion 303, Inc. - EIR, 2003-09-25
September, 2007 FDA 483 Surgistar Inc - Form 483, 2007-09-27
February, 2004 FDA 483 Defender SD Manufacturing LLC - Form 483, 2004-02-24
November, 2010 FDA 483 Syntron Bioresearch Inc - Form 483, 2010-11-30
August, 2011 FDA 483 Diazyme Laboratories - Form 483, 2011-08-25
July, 2011 EIR Organogenesis Inc - EIR, 2011-07-29
July, 2007 FDA 483 Response NuVasive Inc - Form 483R, 2007-08-01
November, 2005 FDA 483 Diazyme Laboratories - Form 483, 2005-11-09
May, 2000 FDA 483 Welch Allyn Inc - Form 483, 2000-05-09
July, 2009 FDA 483 Axelgard Mfg Co Ltd - Form 483, 2009-07-02
June, 2003 FDA 483 Magne Vu - Form 483, 2003-06-11
July, 2003 FDA 483 BioMedical Life Systems, Inc. - Form 483, 2003-07-17
August, 2009 FDA 483 CMR Naviscan Corporation - Form 483, 2009-08-27
May, 2009 FDA 483 Alere San Diego, Inc. - Form 483, 2009-05-08
June, 2003 FDA 483 Response Magne Vu - Form 483R, 2003-06-24
July, 2007 EIR NuVasive Inc - EIR, 2007-07-02
May, 2001 FDA 483 Phamatech - Form 483, 2001-05-04
February, 2011 FDA 483 Aubrey Inc - Form 483, 2011-02-04
July, 2003 FDA 483 Boston Scientific Corporation - Form 483, 2003-07-03

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more